This reportdescribes an interlaboratory comparison of enzymatic serum glucose methods as currently applied inseveral instrumental adaptations. Four spectrophotOmetric, hexokinase-based methods used with the Du Pont "aca," the Abbott "Bichromatic Analyzer," the Aminco 'Rotochem," and the Technicon "AutoAnalyzer II" were compared withglucoseoxidase-based methods as used with the Beckman "GlucoseAnalyzer"and the "AutoAnalyzer II." We analyzed both normal samples and samples that contained potential interfering substances or were otherwise abnormal. Although all methods were satisfactorily precise, methodological bias was noted in several cases, particularly with abnormal specimens. The hexokinase-based methods were generally more variable. The most consistent data were obtainedfrom thetwo glucose oxidasemethods and the Du Pont aca. Resultsof this studycomprise partof the background information required fordevelopmentof an accurate glucose reference method under the auspices of the AACC Standards Committee.
their associates, undertook an interlaboratory comparison (three laboratories) of enzymatic glucose methods. Particular emphasis was placed on widely used instrumental adaptations of these methods that were available in the authors' laboratories. Although none of the methods studied here was proposed as a reference method in its present form, the comparative results obtained would be useful in establishing the basis for additional investigations.
The plan of this interlaboratory comparison included determination of values for serum glucose by four hexokinase-based and two glucose oxidase-based procedures. In addition to normal samples, those with known potential interferences-e.g., increased concentrations of urea, uric acid, creatinine, bilirubin, and hemoglobin-would be analyzed. A statistical analysis of the resulting data would indicate method bias, precision, and any effects of interfering substances in the respective procedures.
Material and Methods

Instrumentation and Reagents
HK-ABA:5
The Abbott "Bichromatic Analyzer"
(ABA-100; Abbott ScientificProducts Division, South Pasadena, Calif. 91030) was used with Abbott "A-Gent" reagent mixture for the end-point, spectrophotometric determination of glucose according to the following reactions: Glucose + ATP --s
Mg2'
glucose-6-phosphate
Glucose-6-phosphate + NAD + H20
6-phosphogluconate + NADH (2)
Abbott literature givesthe following composition, per liter, fortheirreagent:2 mmol ATP, Na2; 6.0mmol Mg aspartate; 1.5mmol NAD; 50 mmol triethanolamine . HC1; 16.5 mmol Na2CO3; 9.0 mmol K2C204; 833 U hexokinase;and 1667 U glucose-6-phosphate dehydrogenase.The sample (10gil) isdilutedwith the reconstituted reagentmixture (1000 gil) intothe 32-placeplastic cuvet and incubatedfor5 mm at 37 #{176}C. The absorbance of a reagentblank cuvet is subtracted from the absorbance of subsequent sample cuvets.
All absorbance values are measured as the difference between two wavelengths (340 and 380 nm), to provide a correction for spectral interferences. The instrument is calibrated with aqueous glucose standards as samples. The use of G-6-PD from Leuconostoc mesenteroides with NAD+ in this reagent was reported by Bondar and Mead (1) .
HK-AAII:
The "AutoAnalyzer II" (Technicon Instruments Corp., Tarrytown, N. Y. 10591) was used with the hexokinase-baseddeterminationas reported by Widdowson and Penton (2) . Analytical reactions are the same as shown in equations1 and 2 above, with the use of the Abbott A-Gent reagent mixture. The system includesa dual-channelcolorimeterin which the absorbancesat 340 nm of samples diluted with saline(9 g/liter) are subtractedfrom the absorbances of samples dilutedwith the hexokinase reagent. The two continuous-flow channels operate in parallel, and sample and blank undergo equal dilution ratios. The concentration of glucose in the samples is calculated by comparison with aqueous glucose standards.
HK-ROTO:
The Aminco "Rotochem" centrifugal analyzer (American Instrument Co., Silver Spring, Md. 20910) was operated according to the procedure of Hasson et al. (3) with the hexokinase reaction shown in equations 1 and 2,and the Abbott A-Gent reagent mixture. The measurement is performed as an end-point analysis, sample glucose concentration being proportional to the total change in absorbance that occurs after mixing and incubation. In this modification of the method of Tiffany et al. (4) , measurement of a separate serum blank is eliminated by fitting a cubic curve to the initial portion of the reaction rate. Sample blank absorbances are thus calculated by extrapolation back to zero time, and subtracted from the final absorbance values. Aqueous glucose solutions are used for standardization.
HK-aca:
The Automatic Clinical Analyzer ("aca"; E. I. du Pont Instrument Products Division, Wilmington, Del. 19898) was used with the hexokinase reaction shown in equations 1 and 2, except that NADP replaces NAD+ as the coenzyme. An evaluation of the aca methods, including glucose, was reported by Westgard and Lahmeyer (5) . In this analytical system, reagents are provided by the manufacturer in pre-measured, single-use packets in dry form. Absorbance readings are taken in the photometer at two wavelengths (340 and 383 nm) after incubation of the pack at 37 #{176}C for about 6 mm. The absorbance difference is converted to glucose concentration based on instrument calibration with aqueous glucose standards.
GO-AAII:
The AutoAnalyzer IIwas used with the glucoseoxidase method reported by Gochman and Schmitz (6) (4) Dialysis is used to remove proteins, turbidity, and other macromolecular substances from the colorimetnc reaction mixture. The system is standardized with aqueous glucose solutions.
GO-ORM:
The Beckman Glucose Analyzer (7) was used to determine glucoseby the oxygen ratemethod with use ofglucoseoxidase. The rateofoxygen depletion in reaction 3 above is monitored by an oxygen electrode, and the maximum rate is converted to glucose concentration.
Calibration is performed with aqueous glucose standards. Peroxide is destroyed as it is formed in two reactions that prevent conversion to molecular oxygen:
11202+ 2 + 2r 12 + 21120
Procedure (6) Serum samples forthe interlaboratory comparison were collected from those submitted to the hospital clinical laboratory. To providesufficient sample volume for all analyses, each sample was prepared by thoroughly mixing several individual specimens. These samples, thus prepared, were each divided into three aliquots (one for each laboratory) with a single accession number, then frozen. Samples were prepared (number given in parentheses, total of 108) from specimens in four categories according to the following criteria:
Normal with respectto concentrationof urea nitrogen, no visible evidenceof bilirubinemia or lipemia,and without regard to possibleabnormal concentrations ofglucoseor otherconstituents (30).
Above-normal urea nitrogen: Above-normal urea nitrogen concentration, without regard to possible abnormal concentrations ofother constituents (23). Above-normal uric acid or creatinine:
Above-normal concentration of either uric acid or creatinine, without regard to possible abnormal concentrations of other constituents (32).
Above-normal
bilirubin:
Above-normal concentration of bilirubin, without regard to possible abnormal concentrations of other constituents (23).
For studies of hemoglobin interference an erythrocyte hemolysate was prepared by twice washing 10 ml of heparinized human erythrocytes with 5 ml ofNaC1 solution (9 g/liter). De-ionized water, 10 ml, was added to the washed cells and mixed. The resulting hemolysate was centrifuged and the supernatant Various volumes of the hemolysate added to aliquots of the serum pool provideda range ofsixhemoglobin concentrations. De-ionizedwater was added to adjust forvolume changes and maintain a constantdilution ofthe serum pool.The sixserum poolswere analyzed for hemoglobin concentration by the Ham modification of the benzidine method (8) .
The frozen aliquots described above and the hemoglobin samples were distributed to each of the three participating laboratories for duplicate analysis of glucose by the six instrumental methods described above (Lab. A: HK-ABA, HK-AAII, HK-ROTO; Lab. Table 1 statistically summarizes the glucose results obtained for the four categories of samples and for all 108 samples combined, again with use of the GO-AAII data as an arbitrary reference. The precision of each of the enzymatic glucose methods, calculated (9) from the difference between consecutive duplicate analyses including controls, is summarized in Table 2 . While this approach does not provide information on long-term or even day-to-day precision of the methods, the calculated coefficients of variation reflect the reliability of differences obtained between methods.
Data on analysis of samples to which various amounts of hemolysate were added appear in Table  3 . The observed results for glucose by each of the methods are reported, along with a calculated percent of the zero hemoglobin result. The latter indicates the direction and magnitude of the deviations introduced. Results on the ABA-100 were obtained with a second set of hemolysate-added samples, because this instrument was not available to us at the time the first set was distributed.
Discussion
This report provides numerous observations on the comparability of data on serum glucose, the effect of interfering substances, and the effects of instrumentation on analytical methodology, and should lead to additional investigations in this complex field.
The reader must understand that none of the methods surveyed could be considered as accurate a priori, and therefore for the present all of the data 400 must be reviewed on a relative basis. Even with this limitation, certain trends are observable from the statistical summary reported in Table 1 . Results by the four hexokinase-based methods did not parallel each other in the regression analysis over the limited range of the samples investigated. Results by the hexokinase method on the aca, the glucose oxidaseoxygen rate method, and the glucose oxidase-AutoAnalyzer II method appeared to parallel each other in all parts of the study, and were least influenced by interfering substances. Only in samples with supranormal concentrations of bilirubin did results with the aca depart from the two glucose oxidase methods and show a noticeable negative bias. A similar bias was also observed by Carey et al. (10) when they added biirubin to a serum pool or measured icteric patient samples with the aca.
The above conclusions could not be further elaborated with regard to specific interferences in individual patient samples, because of the use of pooled serum samples. However, the bias introduced by particular categories of interferences is evident. The precision shown in Table 2 , which was very good for all methods, indicates that the larger differences observed between techniques were related to real methodological biases. Westgard and Hunt (11) describe additional statistical techniques that can be applied to the interpretation of method-comparison studies.
The effect of added hemolysate on results for glucose, as obtained by the enzymatic methods, produced no unusual findings. Table 3 shows that the hexokinase methods on the AAII, Rotochem, ABA-100, and the GO-AAII procedure were unaffected at all hemoglobin concentrations, while the GO-ORM showed slight depression at the highest hemoglobin concentrations. The hexokinase method on the aca showed a significant negative error at high hemoglobin concentrations. Both the ABA-100 and the aca, as noted earlier, use a dual-wavelength blank-subtraction technique with the NADH (NADPH) absorbance maximum at 340 nm corrected for background absorbance at 380 nm (ABA-100) and 383 nm These hemoglobin values apply only to the ABA-iDO data.
(aca). We measured the absorption spectrum of the samples containing added hemolysate and found the absorbance at 383 nni to be slightly higher than that at 340 nm, while at 380 it isalmost identical. This fact makes it evident that the background correction, which assumes identical absorbance of the spectral interference at 340 nm and 383 nm, should over-correct in the presence of hemoglobin and produce falsely low results. This was substantiated by the results obtained with the aca. It should be noted that the highest plasma hemoglobin concentrations tested here are considerably greater than those usually encountered in clinical laboratories.
The influence of instrumental adaptation of analytical methods is clearly illustrated by this interlaboratory survey. This lends further support to the need for a well-defined reference method, against which the bias of various methods under investigation may be judged.
